Get CEO.CA Pro
Real-time Level 2 Market Depth
Click for live demo
back
news releases
7 Sep 2023, 12:00
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus $DMK $ADMP
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus $DMK $ADMP
21 Aug 2023, 09:15
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update $ADMP
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update $ADMP
4 Aug 2023, 13:43
Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering $ADMP
Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering $ADMP
2 Aug 2023, 08:30
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering $ADMP
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering $ADMP
show more ▾
featured articles
April 18, 2024
Drilling Confirms 4 km of Favourable Corridor at Lynx Gold Trend $PUMA $PUXPF.US $PUMXF.US
Drilling Confirms 4 km of Favourable Corridor at Lynx Gold Trend $PUMA $PUXPF.US $PUMXF.US
April 18, 2024
Arizona Metals Intersects 20.1 m at 3.4% CuEq (incl. 3.2 m at 14.9% CuEq) and 38.0 m at 1.4% CuEq (incl. 4.4 m at 7.1% CuEq) in Kay Mine Expansion Drilling $AMC $AZMCF.US
Arizona Metals Intersects 20.1 m at 3.4% CuEq (incl. 3.2 m at 14.9% CuEq) and 38.0 m at 1.4% CuEq (incl. 4.4 m at 7.1% CuEq) in Kay Mine Expansion Drilling $AMC $AZMCF.US
April 17, 2024
WonderFi Appoints Jaime Leverton and Noel Biderman to its Board of Directors $WONDF.US $WNDR $52D0 $CA97818W1077
WonderFi Appoints Jaime Leverton and Noel Biderman to its Board of Directors $WONDF.US $WNDR $52D0 $CA97818W1077
April 17, 2024
American Eagle's 2024 Exploration Program Underway $AMEGF.US $AE $CA02553R1073
American Eagle's 2024 Exploration Program Underway $AMEGF.US $AE $CA02553R1073
show more ▾
CEO.CA Chairman's Briefing
Global Markets. Mining Trends. Every Thursday.
read first
Please read the CEO.CA House Rules before posting.
social
legal
Use of this site indicates acceptance of the
Privacy Policy
and
Terms of Use.
The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
CEO.CA members discuss high-risk penny stocks which can lose their entire value. Only risk what you can afford to lose.
© 2022 - CEO.CA Technologies Ltd.
Adamis Pharmaceuticals Corporation
ADMP
$ADMP ↻
0 online
Today
This week
Search
Subscribe
No more messages to load
Sign up to become a contributing member of the community.
Trending
Personal channels
